GlassScriptPhysician profile
Liberty Clouse
NPI 1962068544
$2,775.17
in general payments reported to CMS, 2019-2025
20 companies · $1,370 in 2025
The $1,370 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $310 · 2024: $1,095 · 2025: $1,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,775.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $553.78 | 2024-2025 | Repatha, Otezla, Otezla |
| Novo Nordisk INC | $542.20 | 2023-2025 | Ozempic, Rybelsus, Saxenda |
| Astrazeneca Pharmaceuticals LP | $368.30 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $228.40 | 2023-2025 | Vraylar |
| Lundbeck LLC | $168.92 | 2023-2025 | Rexulti |
| Glaxosmithkline, LLC. | $159.70 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $156.30 | 2024-2025 | |
| Astellas Pharma US INC | $87.18 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $73.22 | 2024-2025 | |
| Exact Sciences Corporation | $69.55 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.93 | 2023-2024 | Ofev |
| Otsuka America Pharmaceutical, INC. | $58.37 | 2024-2025 | Rexulti |
| Aimmune Therapeutics, INC. | $45.04 | 2024-2025 | Zenpep |
| Corcept Therapeutics | $38.08 | 2025 | Korlym |
| Phathom Pharmaceuticals, INC. | $32.66 | 2024-2025 | Voquezna |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $29.08 | 2023-2025 | Mounjaro, Zepbound |
| Noven Therapeutics, LLC | $27.59 | 2024 | Secuado, Xelstrym |
| Axsome Therapeutics, INC. | $27.47 | 2025 | Auvelity |
| Hologic Sales and Service, LLC | $23.68 | 2025 | Aptima |
| Abiomed | $22.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liberty Clouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.